We are live on ! Find out more
APEN

Apollo Endosurgery, Inc.

Delisted

APEN was delisted on the 3rd of April, 2023.

31 hedge funds and large institutions have $34.2M invested in Apollo Endosurgery, Inc. in 2019 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 12 increasing their positions, 5 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

140% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 5

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

15% more capital invested

Capital invested by funds: $29.7M → $34.2M (+$4.53M)

11% less funds holding

Funds holding: 3531 (-4)

50% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 8

Holders
31
Holders Change
-4
Holders Change %
-11.43%
% of All Funds
0.67%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
4
Increased
12
Reduced
5
Closed
8
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
SCM
1
Stonepine Capital Management
Oregon
$9.65M +$1.38M +395,092 +18%
NCM
2
Nantahala Capital Management
Connecticut
$7.15M +$525K +150,000 +9%
CI
3
CPMG Inc
Texas
$4.76M
GS
4
Gagnon Securities
New York
$3.23M +$40.4K +11,534 +1%
Luther King Capital Management (LKCM)
5
Luther King Capital Management (LKCM)
Texas
$2.05M
GA
6
Gagnon Advisors
New York
$1.94M
Russell Investments Group
7
Russell Investments Group
United Kingdom
$1.32M -$41.6K -11,904 -3%
Vanguard Group
8
Vanguard Group
Pennsylvania
$958K +$292K +83,541 +48%
Goldman Sachs
9
Goldman Sachs
New York
$578K +$120K +34,249 +28%
NSEDCP
10
NJ State Employees Deferred Compensation Plan
New Jersey
$486K +$35K +10,000 +8%
Dimensional Fund Advisors
11
Dimensional Fund Advisors
Texas
$460K
Renaissance Technologies
12
Renaissance Technologies
New York
$266K -$10.8K -3,100 -4%
FPC
13
Falcon Point Capital
California
$243K +$4.86K +1,390 +2%
Geode Capital Management
14
Geode Capital Management
Massachusetts
$233K
WVP
15
Worth Venture Partners
New Jersey
$212K -$177K -50,554 -47%
AAP
16
Ardsley Advisory Partners
Connecticut
$182K +$1.09K +311 +0.6%
BlackRock
17
BlackRock
New York
$99K +$10K +2,865 +12%
Northern Trust
18
Northern Trust
Illinois
$96K -$15.4K -4,398 -15%
Jacobs Levy Equity Management
19
Jacobs Levy Equity Management
New Jersey
$64K +$59.5K +17,004 New
UOTTAIMCU
20
University of Texas/Texas AM Investment Management Co (UTIMCO)
Texas
$58K
SFS
21
Strategic Financial Services
New York
$51K
Millennium Management
22
Millennium Management
New York
$45K +$1.05K +300 +3%
Bank of New York Mellon
23
Bank of New York Mellon
New York
$45K +$42.1K +12,038 New
Bank of America
24
Bank of America
North Carolina
$8K +$2.62K +748 +54%
RWA
25
Ropes Wealth Advisors
Massachusetts
$6K +$1.05K +300 +23%

APEN Hedge Fund Activity: Q1 2019 in Review

31 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Apollo Endosurgery, Inc. (APEN) for Q1 2019, worth a combined $34.2M — up 15% from $29.7M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of APEN and 4 opened new positions — a net loss of 4 holders — while 5 trimmed existing stakes and 12 added.

The largest buyer was Stonepine Capital Management, adding an estimated $1.38M. The largest seller was Bridgeway Capital Management, exiting entirely with an estimated $273K sold.

  • 31 institutional investors held Apollo Endosurgery, Inc. (APEN) as of Q1 2019, down from 35 in Q4 2018.
  • Funds reported $34.2M of Apollo Endosurgery, Inc. stock for Q1 2019, up 15% quarter-over-quarter.
  • 4 funds opened new Apollo Endosurgery, Inc. positions in Q1 2019 and 8 closed out, a net change of -4 holders.
  • The largest Apollo Endosurgery, Inc. buyer in Q1 2019 was Stonepine Capital Management, an estimated $1.38M added.
  • The largest Apollo Endosurgery, Inc. seller in Q1 2019 was Bridgeway Capital Management, an estimated $273K sold.

Based on aggregated 13F filings for Q1 2019.